ASCO Education

191 Episodes

1. Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)

   Published: 6/27/2018
2. Self-Evaluation: Special histologies - lymphoma: Primary CNS, appropriate first line therapy for newly diagnosed primary CNS lymphoma

   Published: 6/20/2018
3. ASCO Guideline: Fertility Preservation in Patients with Cancer

   Published: 6/13/2018
4. Self-Evaluation: EGFR Mutation

   Published: 6/6/2018
5. Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer

   Published: 5/30/2018
6. ASCO Guidelines: Outpatient Management of Fever and Neutropenia

   Published: 5/23/2018
7. Self-Evaluation: NSCLC Treatment Metastatic

   Published: 5/16/2018
8. Adjuvant Treatment in Melanoma: Recent Advances

   Published: 5/9/2018
9. Recently Approved Drugs: Blinatumomab for B-cell precursor ALL

   Published: 5/2/2018
10. Guidelines: Management of Immune-Related Adverse Events

    Published: 4/25/2018
11. Treatment Effects & Transition to Survivorship for AYA Patients

    Published: 4/18/2018
12. EHR Chemotherapy Error: Breast Cancer

    Published: 4/11/2018
13. Continuity of Care for AYAs

    Published: 4/4/2018
14. Self-Evaluation: Clinical Trials Informed Consent Process

    Published: 3/28/2018
15. Self-Evaluation: Clinical Trials

    Published: 3/14/2018
16. Self-Evaluation: NSCLC

    Published: 2/14/2018
17. Self-Evaluation: Breast Cancer

    Published: 2/7/2018
18. Self-Evaluation: Metastatic Breast Cancer

    Published: 12/13/2017
19. ASCO Guidelines: Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer Update

    Published: 12/6/2017
20. Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer

    Published: 11/22/2017